Alignment Healthcare Announces Board and Executive Changes

TL;DR

Alignment Healthcare shakes up board and exec pay. Big changes coming?

AI Summary

Alignment Healthcare, Inc. announced on January 13, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for key personnel.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Changes in leadership and compensation can introduce uncertainty about future strategy and operational stability.

Key Players & Entities

• Alignment Healthcare, Inc. (company) — Registrant
• January 13, 2025 (date) — Date of earliest event reported

FAQ

Key Financial Figures

• $0.001 — ich registered Common Stock, par value $0.001 per share ALHC The NASDAQ Stock Market
• $40 million — sensus adjusted EBITDA of approximately $40 million in 2025. 2025 guidance will be provided
• $2,665 — Membership 184,000 186,000 Revenue $2,665 $2,680 Adjusted Gross Profit 1 $282
• $2,680 — ip 184,000 186,000 Revenue $2,665 $2,680 Adjusted Gross Profit 1 $282 $297
• $282 — ,665 $2,680 Adjusted Gross Profit 1 $282 $297 Adjusted EBITDA 2 ($10) $5
• $297 — $2,680 Adjusted Gross Profit 1 $282 $297 Adjusted EBITDA 2 ($10) $5 1.Adju
• $10 — fit 1 $282 $297 Adjusted EBITDA 2 ($10) $5 1.Adjusted gross profit is a non
• $5 — $282 $297 Adjusted EBITDA 2 ($10) $5 1.Adjusted gross profit is a non-GAAP

Filing Documents

• alhc-20250113.htm (8-K) — 43KB
• pressreleasedraft_alhcxjpm.htm (EX-99.1) — 18KB
• jpm2025deckvf.htm (EX-99.2) — 23KB
• jpm2025deckvf001.jpg (GRAPHIC) — 64KB
• jpm2025deckvf002.jpg (GRAPHIC) — 206KB
• jpm2025deckvf003.jpg (GRAPHIC) — 94KB
• jpm2025deckvf004.jpg (GRAPHIC) — 121KB
• jpm2025deckvf005.jpg (GRAPHIC) — 162KB
• jpm2025deckvf006.jpg (GRAPHIC) — 125KB
• jpm2025deckvf007.jpg (GRAPHIC) — 152KB
• jpm2025deckvf008.jpg (GRAPHIC) — 112KB
• jpm2025deckvf009.jpg (GRAPHIC) — 129KB
• jpm2025deckvf010.jpg (GRAPHIC) — 102KB
• jpm2025deckvf011.jpg (GRAPHIC) — 123KB
• jpm2025deckvf012.jpg (GRAPHIC) — 98KB
• jpm2025deckvf013.jpg (GRAPHIC) — 123KB
• jpm2025deckvf014.jpg (GRAPHIC) — 99KB
• jpm2025deckvf015.jpg (GRAPHIC) — 98KB
• 0001628280-25-001253.txt ( ) — 2720KB
• alhc-20250113.xsd (EX-101.SCH) — 2KB
• alhc-20250113_lab.xml (EX-101.LAB) — 22KB
• alhc-20250113_pre.xml (EX-101.PRE) — 13KB
• alhc-20250113_htm.xml (XML) — 3KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. Members of the Company's senior management team are scheduled to meet with investors and analysts at an industry conference and various other meetings on January 13-16, 2025. During the conference and meetings, the Company intends to address aspects of its prospects and performance as described below. The date and time of presentations to investors are available via the Investor Relations calendar of events and presentations on the Company's website at www.alignmenthealth.com. The Company's presentation during the industry conference on January 15, 2025 is expected to be webcast and a replay will be available on the Company's Investor Relations website. Update on 2025 Membership Outlook, 2025 Profitability Expectations and Full-Year 2024 Guidance The Company has completed the Annual Enrollment Period ("AEP") for 2025 and currently estimates that it will have approximately 209,900 members enrolled in its HMO and PPO contracts ("Health Plan Members") as of January 1, 2025. This figure represents Health Plan Member growth of approximately 35% year over year when compared with the Company's Health Plan Membership as of January 1, 2024. Additionally, the Company expects to have 225,000 to 231,000 members as of December 31, 2025, representing approximately 22% to 25% growth relative to the midpoint of the Company's latest Health Plan Membership guidance for year-end 2024 provided on October 29, 2024. Furthermore, the company is reiterating confidence in attaining consensus adjusted EBITDA of approximately $40 million in 2025. 2025 guidance will be provided at its fourth-quarter 2024 earnings call. Lastly, the Company is reaffirming its full-year 2024 guidance ranges on health plan membership, revenue, adjusted gross profit and adjusted EBITDA provided October 29, 2024. The 2024 financial guidance was previously issued in the Company's press release dated October 29, 2024, as follows: $ Millions Low High Health Plan Mem

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits: Exhibit Number Description 99.1 Press Release dated January 13, 2025 99.2 Alignment Healthcare, Inc. Investor Presentation dated January 13, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Alignment Healthcare, Inc. Date: January 13, 2025 By: /s/ Thomas Freeman Thomas Freeman Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR